Skip to content

US · AARD

Aardvark Therapeutics, Inc. Common Stock

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Biotechnology
Headquarters
San Diego, CA 92122

Price · as of 2026-09-08

$5.33

Market cap 164.57M

Price history

Weekly OHLC price history for AARD, USD per share
WeekOpenHighLowCloseVolume
Feb 10, 2025 – Feb 14, 2025$15.18$15.18$11.55$13.300
Feb 17, 2025 – Feb 21, 2025$13.39$19.58$12.58$13.740
Feb 24, 2025 – Feb 28, 2025$14.22$15.80$12.21$12.730
Mar 3, 2025 – Mar 7, 2025$12.94$13.60$9.21$10.130
Mar 10, 2025 – Mar 14, 2025$10.90$11.78$9.40$10.010
Mar 17, 2025 – Mar 21, 2025$9.80$10.51$8.60$9.910
Mar 24, 2025 – Mar 28, 2025$9.91$10.38$7.74$7.740
Mar 31, 2025 – Apr 4, 2025$7.46$9.70$6.79$8.160
Apr 7, 2025 – Apr 11, 2025$8.27$8.30$4.88$7.140
Apr 14, 2025 – Apr 17, 2025$7.12$7.99$6.89$7.000
Apr 21, 2025 – Apr 25, 2025$6.86$8.55$6.75$7.930
Apr 28, 2025 – May 2, 2025$8.01$13.56$8.01$12.860
May 5, 2025 – May 9, 2025$13.25$13.25$10.00$10.420
May 12, 2025 – May 16, 2025$10.40$11.38$8.50$9.890
May 19, 2025 – May 23, 2025$10.02$11.50$9.67$10.500
May 26, 2025 – May 30, 2025$10.48$10.93$9.76$10.440
Jun 2, 2025 – Jun 6, 2025$10.72$12.22$10.72$11.810
Jun 9, 2025 – Jun 13, 2025$12.19$12.53$10.50$10.740
Jun 16, 2025 – Jun 20, 2025$10.96$12.18$10.29$11.130
Jun 23, 2025 – Jun 27, 2025$10.54$16.32$10.54$13.390
Jun 30, 2025 – Jul 3, 2025$14.10$14.14$12.82$13.920
Jul 7, 2025 – Jul 11, 2025$14.11$14.54$12.11$12.170
Jul 14, 2025 – Jul 18, 2025$12.01$12.58$11.09$11.620
Jul 21, 2025 – Jul 25, 2025$11.61$15.17$11.51$14.700
Jul 28, 2025 – Aug 1, 2025$14.72$15.01$11.50$12.130
Aug 4, 2025 – Aug 8, 2025$12.47$13.63$11.50$11.990
Aug 11, 2025 – Aug 15, 2025$12.41$12.41$9.75$10.780
Aug 18, 2025 – Aug 22, 2025$10.85$10.85$9.32$9.770
Aug 25, 2025 – Aug 29, 2025$9.80$9.80$8.20$8.300
Sep 1, 2025 – Sep 5, 2025$8.45$9.09$8.03$8.600
Sep 8, 2025 – Sep 12, 2025$8.68$8.70$7.50$8.590
Sep 15, 2025 – Sep 19, 2025$9.01$11.82$8.70$10.890
Sep 22, 2025 – Sep 26, 2025$10.95$13.50$10.86$13.230
Sep 29, 2025 – Oct 3, 2025$13.60$16.35$12.71$16.080
Oct 6, 2025 – Oct 10, 2025$16.49$17.94$15.71$16.260
Oct 13, 2025 – Oct 17, 2025$16.31$16.39$12.32$12.810
Oct 20, 2025 – Oct 24, 2025$12.77$12.86$10.65$10.700
Oct 27, 2025 – Oct 31, 2025$11.00$12.16$10.23$10.690
Nov 3, 2025 – Nov 7, 2025$10.66$10.94$9.34$10.140
Nov 10, 2025 – Nov 14, 2025$10.21$11.51$9.75$9.920
Nov 17, 2025 – Nov 21, 2025$9.97$11.23$8.82$9.370
Nov 24, 2025 – Nov 28, 2025$9.53$10.44$9.28$9.980
Dec 1, 2025 – Dec 5, 2025$9.95$13.77$9.18$13.560
Dec 8, 2025 – Dec 12, 2025$13.80$16.00$12.54$14.430
Dec 15, 2025 – Dec 19, 2025$15.64$15.75$12.90$13.770
Dec 22, 2025 – Dec 26, 2025$13.81$15.33$13.58$13.650
Dec 29, 2025 – Jan 2, 2026$13.90$14.34$12.50$13.190
Jan 5, 2026 – Jan 9, 2026$13.48$15.00$12.78$14.270
Jan 12, 2026 – Jan 16, 2026$14.27$16.00$14.25$15.370
Jan 19, 2026 – Jan 23, 2026$15.00$16.60$14.80$15.010
Jan 26, 2026 – Jan 30, 2026$14.94$15.37$12.43$12.990
Feb 2, 2026 – Feb 6, 2026$12.84$13.83$11.14$12.650
Feb 9, 2026 – Feb 13, 2026$12.65$13.58$12.00$12.100
Feb 16, 2026 – Feb 20, 2026$12.09$13.00$12.00$12.320
Feb 23, 2026 – Feb 27, 2026$12.42$12.90$12.06$12.490
Mar 2, 2026 – Mar 6, 2026$5.98$6.00$4.74$5.850
Mar 9, 2026 – Mar 13, 2026$5.70$6.50$4.83$5.090
Mar 16, 2026 – Mar 20, 2026$5.07$5.49$4.06$4.070
Mar 23, 2026 – Mar 27, 2026$4.06$4.17$3.35$3.550
Mar 30, 2026 – Apr 2, 2026$3.58$4.30$3.49$4.300
Apr 6, 2026 – Apr 10, 2026$4.30$4.39$3.80$3.940
Apr 13, 2026 – Apr 17, 2026$3.88$5.37$3.88$5.230
Apr 20, 2026 – Apr 24, 2026$5.16$5.83$5.10$5.390
Apr 27, 2026 – May 1, 2026$5.40$5.70$4.88$5.460
May 4, 2026 – May 8, 2026$5.38$5.93$5.24$5.440
May 11, 2026 – May 15, 2026$5.45$6.79$4.10$4.570
May 18, 2026 – May 22, 2026$4.49$5.11$4.05$4.540
May 25, 2026 – May 29, 2026$4.58$4.67$3.90$4.110
Jun 1, 2026 – Jun 5, 2026$3.99$4.12$3.66$3.680
Jun 8, 2026 – Jun 12, 2026$3.73$3.99$3.40$3.900
Jun 15, 2026 – Jun 18, 2026$3.90$4.10$3.65$3.930
Jun 22, 2026 – Jun 26, 2026$3.96$5.53$3.91$4.790
Jun 29, 2026 – Jul 2, 2026$4.78$5.99$4.70$5.700
Jul 6, 2026 – Jul 10, 2026$5.59$7.92$4.66$7.600
Jul 13, 2026 – Jul 17, 2026$7.35$7.92$5.73$5.860
Jul 20, 2026 – Jul 24, 2026$5.87$6.90$5.35$6.320
Jul 27, 2026 – Jul 31, 2026$6.40$6.80$5.30$6.600
Aug 3, 2026 – Aug 7, 2026$6.65$8.12$6.64$7.900
Aug 10, 2026 – Aug 14, 2026$7.76$7.76$6.18$6.540
Aug 17, 2026 – Aug 21, 2026$6.54$7.51$5.76$6.820
Aug 24, 2026 – Aug 28, 2026$6.75$7.31$5.62$5.790
Aug 31, 2026 – Sep 4, 2026$5.70$6.25$5.15$5.380
Sep 7, 2026 – Sep 8, 2026$5.28$5.55$5.10$5.33

InvestorsCraft valuation

Fair value (AI, DCF / IC, Graham) for Aardvark Therapeutics, Inc. Common Stock (AARD) is available to Pro members and via the machine API.

  • AI valuation — available
  • Intrinsic / IC value — available
  • Upside vs price — available
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Aardvark Therapeutics, Inc. Common Stock

        Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's natural regulatory systems (innate homeostatic pathways) to combat metabolic disorders. The company's primary experimental drug, ARD-101, is an orally administered, gut-specific small molecule. It functions as an agonist, targeting particular bitter taste receptors found within the gut lumen. ARD-101 is currently undergoing a Phase III clinical trial for managing excessive hunger (hyperphagia) associated with Prader-Willi Syndrome. Additionally, it is in a Phase II trial for addressing hyperphagia linked to acquired hypothalamic obesity, often a result of craniopharyngioma treatments like surgery or radiation therapy. Aardvark Therapeutics is also advancing ARD-201, which is currently in Phase I clinical trials for the treatment of obesity. Established in 2017, the company is based in San Diego, California.

        CEO
        Tien-Li Lee
        Employees
        40
        Beta
        3.81

        Peer comparison

        Same-industry comparables, ranked by market cap.

        The peer comparison table is shown only to users with a Pro subscription.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice.